Clinical Trial Update: Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy and safety of Rina-S in participants with Non-small cell lung cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Rina-S

Snippet

Sponsor: Genmab | Conditions: Non-small Cell Lung Cancer (NSCLC) | Phase 2 | Status: RECRUITING